Companies /Healthcare

Avalo Therapeutics Inc

NASDAQ: AVTX Biotechnology
$16.69
▲ $0.11 (+0.66%) today
Markets closed · 10:10pm ET
Today · % change

Fundamentals

Market Cap
$889.2M
Revenue (TTM)
$59,000
EPS (TTM)
$-4.55
52-Week Range
$11 – $24
Street Target
$44.08

About Avalo Therapeutics

Avalo Therapeutics Inc, originally known as Avantium N.V., is a pioneer in the field of renewable chemistry based in Amsterdam, the Netherlands. Founded in 2000, the company focuses on creating sustainable chemical solutions, notably developing plant-based recyclable plastics like polyethylene furanoate (PEF). Avalo Therapeutics is also known for its innovative technologies such as Flowrence for catalyst testing, and its efforts in transforming non-food plant materials into valuable industrial sugars and lignin. Their work supports the production of eco-friendly materials, contributing to a greener future.

AVTX Coverage